![$5.275 billion for NIH is a healthy chunk of change—but read the fine print](https://cdn.cancerletter.com/media/2020/07/23153825/46-28-helicopter-web_4x3.jpg)
![$5.275 billion for NIH is a healthy chunk of change—but read the fine print](https://cdn.cancerletter.com/media/2020/07/23153825/46-28-helicopter-web_4x3.jpg)
Cover Story
COVID-19 & Cancer
A House subcommittee July 7 marked up a spending bill that proposes a $5.275 billion increase for NIH.
COVID-19 Updates
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Lei Zheng named executive director of Mays Cancer Center
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”